NCT05197556View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

February 24, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

April 4, 2023

Conditions
Obesity
Interventions
DRUG

HSG4112

Once-daily oral administration

DRUG

Placebo

Once-daily oral administration

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

Glaceum
All Listed Sponsors
collaborator

Gangnam Severance Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

Seoul National University Hospital

OTHER

collaborator

SMG-SNU Boramae Medical Center

OTHER

lead

Glaceum

INDUSTRY

NCT05197556 - A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients | Biotech Hunter | Biotech Hunter